Rate the Article: Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 1 | Views: 248 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medicine | India | Volume 12 Issue 1, January 2023 | Rating: 4.3 / 10


Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation

Dr Sushant P Wagaj, Dr. C. A. Kante


Abstract: Pulmonary embolism is a medical emergency. Most common risk factors-immobility, malignancy, pregnancy, surgery, cigarette smoking, hypertension, obesity and in Indian population hyperhomocysteinemia. COVID infection represents a prothrombotic state but introduction of COVID vaccines to a lesser extent increased the risk of unprovoked venous thrombosis and pulmonary thrombosis.


Keywords: COVID vaccine, pulmonary embolism


Edition: Volume 12 Issue 1, January 2023,


Pages: 853 - 854



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top